Cutaneous thrombosis associated with eltrombopag treatment for immune thrombocytopenia

被引：6
|
作者：
Iinuma, Shin [1 ]
Nagasawa, Yusuke [1 ]
Sasaki, Kenta [1 ]
Hayashi, Kei [1 ]
Kanno, Kyoko [1 ]
Honma, Masaru [1 ]
Sugawara, Motoshi [2 ]
Kinouchi, Motoshi [2 ]
Obata, Masahiko [3 ]
Ishida-Yamamoto, Akemi [1 ]
机构：
[1] Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan
[2] Asahikawa Red Cross Hosp, Dept Dermatol, Asahikawa, Hokkaido, Japan
[3] Asahikawa Red Cross Hosp, Dept Diagnost Pathol, Asahikawa, Hokkaido, Japan
来源：
JOURNAL OF DERMATOLOGY | 2020年 / 47卷 / 02期
关键词：
THROMBOEMBOLISM; METAANALYSIS; ITP;
D O I：
10.1111/1346-8138.15171
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E57 / E58
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia
    Chen, Mo
    Fang, Jian-Pei
    Zhou, Chuan-Xin
    Li, Xin-Yu
    Lin, Shao-Fen
    Xu, Lu-Hong
    HEMATOLOGY, 2021, 26 (01) : 31 - 36
  • [22] Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    BLOOD, 2018, 132
  • [23] ELTROMBOPAG VS ROMIPLOSTIN IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIA. PRACTICAL ASPECTS
    Jimenez, Barcenas Reyes
    Mingot, Castellano Maria Eva
    Pedrote, Amador Begona
    Soriano, Martinez Maria
    Nunez, Vazquez Ramiro Jose
    Rodriguez, Martorell Fco Javier
    Perez, Simon Jose Antonio
    HAEMATOLOGICA, 2020, 105 : 284 - 285
  • [24] The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States
    Tremblay, Gabriel
    Dolph, Mike
    Roy, Anuja Nidumolu
    Said, Qayyim
    Forsythe, Anna
    CLINICAL THERAPEUTICS, 2020, 42 (05) : 860 - +
  • [25] Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
    Park, Rojin
    BLOOD RESEARCH, 2015, 50 (01) : 1 - 2
  • [26] Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim
    Nakazato, Tomonori
    Ito, Chisako
    Mihara, Ai
    Aisa, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 291 - 293
  • [27] Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim
    Tomonori Nakazato
    Chisako Ito
    Ai Mihara
    Yoshinobu Aisa
    International Journal of Hematology, 2013, 97 : 291 - 293
  • [28] An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (11) : 2673 - 2677
  • [29] Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease
    Juan Wang
    Min Dai
    Qiong Fu
    Sheng Chen
    Scientific Reports, 11
  • [30] Spotlight on Eltrombopag in Treatment-Refractory Chronic Primary Immune Thrombocytopenia
    Karly P. Garnock-Jones
    BioDrugs, 2011, 25 : 401 - 404
12345